cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.zmwxd3
title: Occurrence Download

description: A dataset containing 71 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is China",
 "TaxonKey is Dimocarpus confinis (F.C.How & C.N.Ho) H.S.Lo"
 ]
}

 The dataset includes 71 records from 7 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046900-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.wfqewj
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON ((-78.9061561999999981 40.3057844000000003, -78.9061561999999981 40.3064943199999988, -78.9061561999999981 40.3071207200000003, -78.9061561999999981 40.3076635999999979, -78.9061561999999981 40.3085405599999973, -78.9061561999999981 40.3090416800000000, -78.9061561999999981 40.3099604000000014, -78.9049016599999931 40.3099604000000014, -78.9040652500000022 40.3099604000000014, -78.9027688299999994 40.3099604000000014, -78.9017233299999958 40.3099604000000014, -78.9010542099999981 40.3099604000000014, -78.9000923400000005 40.3099604000000014, -78.8992559999999941 40.3099604000000014, -78.8992559999999941 40.3093339999999998, -78.8992559999999941 40.3084988000000024, -78.8992559999999941 40.3078724000000008, -78.8992559999999941 40.3072042399999972, -78.8992559999999941 40.3066613599999997, -78.8992559999999941 40.3057844000000003, -78.9001759800000002 40.3057844000000003, -78.9010960300000050 40.3057844000000003, -78.9017233299999958 40.3057844000000003, -78.9026433700000069 40.3057844000000003, -78.9039397899999955 40.3057844000000003, -78.9048180199999933 40.3057844000000003, -78.9055707800000050 40.3057844000000003, -78.9061561999999981 40.3057844000000003))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 1932",
 "BasisOfRecord is one of (Human Observation, Living Specimen, Observation, Specimen, Machine Observation)"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0074594-220831081235567/datasets/export for details.
DOI: 10.15468/dl.fqw945
title: Occurrence Download

description: A dataset containing 9242 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Trachemys scripta scripta"
 ]
}

 The dataset includes 9242 records from 65 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0046927-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.4s8vmh
title: Occurrence Download

description: A dataset containing 20 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON ((-78.9385005000000035 40.3302458000000001, -78.9385005000000035 40.3320264199999983, -78.9385005000000035 40.3332135100000002, -78.9385005000000035 40.3340708400000025, -78.9385005000000035 40.3353238700000034, -78.9385005000000035 40.3368407000000033, -78.9377076699999947 40.3368407000000033, -78.9362539100000049 40.3368407000000033, -78.9350644799999941 40.3368407000000033, -78.9340732800000069 40.3368407000000033, -78.9328838400000024 40.3368407000000033, -78.9314300799999984 40.3368407000000033, -78.9295137699999998 40.3368407000000033, -78.9275315000000006 40.3368407000000033, -78.9275315000000006 40.3356536200000022, -78.9275315000000006 40.3346643799999995, -78.9275315000000006 40.3334772999999984, -78.9275315000000006 40.3326859100000021, -78.9275315000000006 40.3314328800000013, -78.9275315000000006 40.3302458000000001, -78.9289851300000009 40.3302458000000001, -78.9300424000000049 40.3302458000000001, -78.9315622400000052 40.3302458000000001, -78.9326195200000029 40.3302458000000001, -78.9341393600000032 40.3302458000000001, -78.9350644799999941 40.3302458000000001, -78.9367825500000038 40.3302458000000001, -78.9385005000000035 40.3302458000000001))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 1932",
 "BasisOfRecord is one of (Human Observation, Living Specimen, Observation, Specimen, Machine Observation)"
 ]
}

 The dataset includes 20 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0074569-220831081235567/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.cnsq95
title: Occurrence Download

description: A dataset containing 23216 species occurrences available in GBIF matching the query:
{
 "and" : [
 "VerbatimScientificName is Leistes superciliaris",
 "BasisOfRecord is one of (Machine Observation, Human Observation)",
 "Year 2011-2021",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen, Specimen, Material citation, Material sample)"
 ]
 }
 }
 ]
}

 The dataset includes 23216 records from 6 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0074700-230530130749713/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.nm6x7f
title: Occurrence Download

description: A dataset containing 1776051 species occurrences available in GBIF matching the query:
(Query is too complex. Can be viewed on the landing page)

 The dataset includes 1776051 records from 1515 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0074703-230530130749713/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00002466
title: A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Ability of Ramelteon 1 mg, 4 mg, and 8 mg to Alleviate the Insomnia Symptoms Associated With Eastward Bound Jet Lag Across 5 Time Zones in Healthy Adult Volunteers

description: The purpose of this study to determine the degree to which ramelteon, once daily (QD), can reduce the insomnia symptoms associated with rapid, eastward travel across 5 time zones.
DOI: 10.25934/00003019
title: A Year 2, Long-Term, Open-Label, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia

description: The objective of the study is to assess the continued safety of the daily coadministration of ABT-335 in combination with rosuvastatin calcium, simvastatin or atorvastatin calcium.
DOI: 10.15468/dl.p62rap
title: Occurrence Download

description: A dataset containing 413 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Pseudohaetera hypaesia Hewitson, 1854"
 ]
}

 The dataset includes 413 records from 32 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002231-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00000510
title: Study TXA107977, a Long-Term Safety Study of a Combination Product Containing Sumatriptan Succinate and Naproxen Sodium for the Treatment of Migraine in Adolescents

description: This study was designed to determine long-term safety of TREXIMET (sumatriptan/naproxen sodium) in adolescents for the acute treatment of migraine.
DOI: 10.25934/00000504
title: A Study to Assess the Pharmacokinetics of Single Escalating Doses of Inhaled GSK961081 DPI (a Dual Pharmacophore) in Healthy Subjects (Part 1) and a Randomised, Double-blind, Double Dummy, Crossover (Incomplete Block) Study to Assess the Safety, Tolerability, Pharmacodynamics (Pulmonary and Systemic) and Pharmacokinetics of 14 Days Dosing With Inhaled GSK961081 DPI Compared With Placebo and Tiotropium Plus Salmeterol in Patients With COPD (Part 2)

description: GSK961081 has previously been administered to healthy subjects in a nebulised formulation and the first part of this study which will be conducted in healthy subjects proposes to bridge the change from nebulised to DPI formulation of GSK961081 before administration to patients. The second part of the study will be conducted in COPD patients and aims to assess the safety and bronchodilator profile of GSK961081 over 24 hours, during 14 days dosing.
DOI: 10.25934/00000501
title: A Single-centre, Randomised, Double-blind, Placebo-controlled, Dose-ascending, 3-cohort Parallel-group Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK573719 Administered as Singledoses (750 μg and 1000 μg) and Repeat Doses Over 14 Days (250 μg-1000 μg Once-daily) of GSK573719 in Healthy Male and Female Subjects.

description: GSK573719 is a high-affinity specific muscarinic receptor (mAChR) antagonist which is being developed for once daily treatment of chronic obstructive pulmonary disease (COPD). The long duration of action of GSK573719 when administered via inhalation in animal models supports the potential for use as a once-daily bronchodilator for COPD
DOI: 10.25934/00004558
title: Efficacy and Safety of Duloxetine Compared With Placebo in Subjects With Stress Urinary Incontinence

description: Study F1J-MC-SBBT will examine the effect of duloxetine treatment in women with SUI. The inclusion and exclusion criteria of this Phase 3 study will ensure that all subjects have a clinical diagnosis of SUI.
DOI: 10.25934/00002075
title: A Randomized, Single-dose, Dose-ascending, Double Blind, Placebo-controlled, 5-way Crossover Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled Doses of GW642444M With Magnesium Stearate in Asthmatic Patients

description: This study will involve the use of a new compound, GW642444 that is being developed for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by acting on cells in the lungs, causing some of the muscles around the lungs to relax and open up better (bronchodilation), making breathing easier. When a medicine is made into a form ready to be given to patients, the active ingredient is often prepared with another ingredient called a salt to help make it stable, and inactive ingredients are often added. Inactive ingredients might be used to help a medicine work better, to make it easier to produce the medicine, or to make it easier to get an accurate dose of medicine. In previous studies the study drug has been given as a dry powder containing either the "H" salt (with the inactive ingredient lactose), or containing the "M" salt (with the inactive ingredients lactose and cellobiose octaacetate). The "M" salt form of the study drug has been altered to contain lactose and a new inactive ingredient called magnesium stearate (instead of cellobiose octaacetate). Participants in this study will receive both the "H" salt (GW642444H) and the new "M" salt (GW642444M) containing magnesium stearate. This study will be the first time the new "M" salt form of the study drug will be given to asthmatic patients.
DOI: 10.25934/00000488
title: A Phase I, Randomized, Double-Blind Study to Assess the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of Repeat Oral Dosing of Casopitant in Healthy Subjects

description: Casopitant may affect liver enzymes that metabolize ketoconazole. This study is designed to test the safety and the extent of the Casopitant affect on ketoconazole levels in healthy human subjects.
DOI: 10.15468/dl.mg6zxy
title: Occurrence Download

description: A dataset containing 7191 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Dactylopterus volitans (Linnaeus, 1758)"
 ]
}

 The dataset includes 7191 records from 174 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002233-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00000481
title: A Single-centre, Randomized, Double-blind Placebo-controlled, Dose-ascending, Cross-over Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Doses of GSK233705, Formulated With the Excipient Magnesium Stearate, in Healthy Volunteers

description: This study will investigate the safety and tolerability of inhaled doses of GSK233705 with a new formulation.
DOI: 10.25934/00000477
title: A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Treatment of Subjects With Asthma

description: This purpose of this study is to show the superiority and long term safety and efficacy of adding a long acting beta agonist (salmeterol) to constant dose of an inhaled corticosteroid (fluticasone propionate) in symptomatic subjects with asthma. The 12-month assessment of asthma control will provide key information on the efficacy and safety of the combination therapy. The safety measure will be an assessment of adverse events
DOI: 10.25934/00000475
title: An Open-label, Randomised, Single-dose, Parallel-group Study to Demonstrate Bioequivalence of Two Formulations and the Effect of Food and Water on One Formulation of Lamotrigine in Healthy Male and Female Volunteers

description: This study intends to demonstrate bioequivalence of two formulations, the effect of food and water on one formulation and safety and tolerability of two formulations of lamotrigine in healthy male and female volunteers
DOI: 10.25934/00000454
title: A Multicentre, Randomised, Partially Blinded, Placebo-controlled, Three-way Crossover, Incomplete Block Design Study to Investigate the Safety, Tolerability, Pharmacodynamics/ Efficacy and Pharmacokinetics of Dual Bronchodilator Therapy With Salmeterol 50µg Twice-daily Plus Two Different Doses of GSK233705B (20 and 50µg Twice-daily), Compared With Placebo, Salmeterol 50µg Twice-daily Alone, and Tiotropium 18µg Once-daily Alone, in Subjects With Chronic Obstructive Pulmonary Disease

description: The safety, tolerability, pharmacokinetics and pharmacodynamics/efficacy profiles of two different doses of GSK233705 will be compared with 2 active comparators and placebo, all medication delivered via dry powder inhaler.
DOI: 10.15468/dl.at8t64
title: Occurrence Download

description: A dataset containing 27563 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Year is 2000,2024",
 "Month is one of (April, May, June)",
 "TaxonKey is one of (Motacilla alba leucopsis (Gould, 1838), Urosphena squameiceps (Swinhoe, 1863), Cyanopica cyanus (Pallas, 1776))",
 "Geometry POLYGON((108 20, 157 20, 157 55, 108 55, 108 20))"
 ]
}

 The dataset includes 27563 records from 45 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002235-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14222278
title: Dataset of the publication:   Spin-crossover nanoparticles anchored on MoS2 layers for heterostructures with tunable strain driven by thermal or light-induced spin switching

description: Dataset of the publication: 

Spin-crossover nanoparticles anchored on MoS2 layers for heterostructures with tunable strain driven by thermal or light-induced spin switching



https://doi.org/10.1038/s41557-021-00795-y

R. Torres-Cavanillas, M. Morant-Giner, G. Escorcia-Ariza, J. Dugay, J. Canet-Ferrer, S. Tatay, S. Cardona-Serra, M. Giménez-Marqués, M. Galbiati, A. Forment-Aliaga, E. Coronado, Nat Chem 2021, 13, 1101.
DOI: 10.5281/zenodo.14222279
title: Dataset of the publication:   Spin-crossover nanoparticles anchored on MoS2 layers for heterostructures with tunable strain driven by thermal or light-induced spin switching

description: Dataset of the publication: 

Spin-crossover nanoparticles anchored on MoS2 layers for heterostructures with tunable strain driven by thermal or light-induced spin switching



https://doi.org/10.1038/s41557-021-00795-y

R. Torres-Cavanillas, M. Morant-Giner, G. Escorcia-Ariza, J. Dugay, J. Canet-Ferrer, S. Tatay, S. Cardona-Serra, M. Giménez-Marqués, M. Galbiati, A. Forment-Aliaga, E. Coronado, Nat Chem 2021, 13, 1101.
DOI: 10.25934/00000072
title: A Study to Evaluate the Effect of Repeat Oral Doses of Darapladib on Cardiac Conduction as Compared to Placebo and a Single Oral Dose of Moxifloxacin

description: This is a study to assess the effects of darapladib on the cardiac conduction of the heart as compared to placebo and moxifloxacin. This a four period crossover design with each period lasting about 10 days. There will be a 7 to 10 day wash out in between each period.
DOI: 10.5281/zenodo.13947021
title: Physical oceanography captured by PolarFront Seaglider SG644 in 2023-08

description: Seaglider SG644 was deployed from 18 to 25 August, 2023 (for details, see the Cruise Report https://doi.org/10.5281/zenodo.10014336

Sibling datasets from the same deployment:



EK80:  https://doi.org/10.5281/zenodo.13946034

UVP6: https://doi.org/10.5281/zenodo.10041063
DOI: 10.5281/zenodo.13947022
title: Physical oceanography captured by PolarFront Seaglider SG644 in 2023-08

description: Seaglider SG644 was deployed from 18 to 25 August, 2023 (for details, see the Cruise Report https://doi.org/10.5281/zenodo.10014336

Sibling datasets from the same deployment:



EK80:  https://doi.org/10.5281/zenodo.13946034

UVP6: https://doi.org/10.5281/zenodo.10041063
DOI: 10.25934/00000441
title: An Open-label, Two Period, Fixed Sequence Study of Healthy Subjects to Assess the Effect of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of [GW679769]

description: This is a two period study of healthy adult subjects to characterize the effect of the dosing of ketoconazole on the the way the body reacts to a dose of GW679769, and to assess the safety profile of oral casopitant with and without ketoconazole. This study will consist of a screening period, two treatment periods and a post-treatment follow-up visit.
DOI: 10.15468/dl.nkqc35
title: Occurrence Download

description: A dataset listing the 274 species recorded in GBIF matching the query:
{
 "and" : [
 "Continent is Europe",
 "Country is Ukraine",
 "DatasetKey is Records of protected animal, plant and fungi species in Ukraine",
 "IucnRedListCategory is one of (CR, EN, VU, NT, LC)"
 ]
}

 The dataset's 274 records were derived from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002224-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14222455
title: Data Grids for examples in Probe Particle Atomic Force Microscopy simulation program (ppafm)

description: These files are used for running the examples for [ppafm](https://github.com/Probe-Particle/ppafm/) program.

The grids are stored in in [.xsf](http://www.xcrysden.org/doc/XSF.html) and [.cube](https://paulbourke.net/dataformats/cube/) format.

The data set compiles both the new examples used in paper  [Advancing scanning probe microscopy simulations: A decade of development in probe-particle models](https://www.sciencedirect.com/science/article/pii/S0010465524002649) as well as older examples.

Notice that the structure does not exactly  reflect the directory structure in the  [example folder of ppafm](https://github.com/Probe-Particle/ppafm/tree/main/examples) to prevent possible redudancy, but is instead flatenized and sorted by molecules.
DOI: 10.5281/zenodo.14222456
title: Data Grids for examples in Probe Particle Atomic Force Microscopy simulation program (ppafm)

description: These files are used for running the examples for [ppafm](https://github.com/Probe-Particle/ppafm/) program.

The grids are stored in in [.xsf](http://www.xcrysden.org/doc/XSF.html) and [.cube](https://paulbourke.net/dataformats/cube/) format.

The data set compiles both the new examples used in paper  [Advancing scanning probe microscopy simulations: A decade of development in probe-particle models](https://www.sciencedirect.com/science/article/pii/S0010465524002649) as well as older examples.

Notice that the structure does not exactly  reflect the directory structure in the  [example folder of ppafm](https://github.com/Probe-Particle/ppafm/tree/main/examples) to prevent possible redudancy, but is instead flatenized and sorted by molecules.
DOI: 10.25934/00000437
title: A Repeat-dose, Open-label, Randomized, Incomplete Block Design in Pediatric Subjects With Asthma, Ages 4 - 11 Years, to Compare Systemic Exposure and Pharmacodynamics of Fluticasone Propionate and Salmeterol Following Advair HFA 45/21mcg (2 Inhalations), ADVAIR® HFA 45/21mcg (2 Inhalations) With Aerochamber Plus Spacer and Advair Diskus 100/50 Twice Daily

description: Collect PK/PD data for this age group to compare ADVAIR DISKUS with ADVAIR HFA
DOI: 10.15468/dl.de7jwx
title: Occurrence Download

description: A dataset containing 61 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Continent is Africa",
 "Country is one of (Kenya, Tanzania, United Republic of)",
 "Geometry POLYGON((30.68167 -5.95879,31.17923 -8.26665,34.80113 -9.04831,35.84737 -8.28464,35.84445 -7.02367,35.74282 -6.2589,34.5293 -5.94247,31.61346 -5.30206,30.68167 -5.95879))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "TaxonKey is Giraffa tippelskirchi Matschie, 1898",
 "Year 2000-2024"
 ]
}

 The dataset includes 61 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002236-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00005705
title: A Phase III, Open-Label Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters

description: This was a Phase III, open-label study conducted at 44 centers in the United States, Canada, and Puerto Rico. 223 subjects who required hemodialysis (HD) and had a dysfunctional HD catheter were enrolled in the study.
DOI: 10.25934/00005706
title: A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters

description: This was a Phase III, open-label, single-arm study that was conducted at 43 centers in the United States and Canada. 251 adult and pediatric patients with dysfunctional central venous catheters (CVCs) were enrolled in the study and treated with one or two doses of tenecteplase.
DOI: 10.25934/00005704
title: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters

description: This was a Phase III, randomized, double-blind, placebo-controlled study conducted at 37 centers in the United States. 150 subjects ≥ 16 years of age who required hemodialysis (HD) and had a dysfunctional HD catheter were enrolled in the study.
DOI: 10.15468/dl.vjatvg
title: Occurrence Download

description: A dataset containing 826 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is one of (Sargentodoxa cuneata (Oliv.) Rehder & E.H.Wilson)"
 ]
}

 The dataset includes 826 records from 14 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002238-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.